These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2236458)

  • 41. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clomipramine in obsessive-compulsive disorder.
    Katz RJ; DeVeaugh-Geiss J; Landau P
    Biol Psychiatry; 1990 Sep; 28(5):401-14. PubMed ID: 2207219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tourette's syndrome and treatment with clomipramine hydrochloride.
    Donahoe DH; Meador M; Fortune T; Llorena R
    W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clomipramine: an antiobsessional tricyclic antidepressant.
    Peters MD; Davis SK; Austin LS
    Clin Pharm; 1990 Mar; 9(3):165-78. PubMed ID: 2180623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.
    Koran LM; Sallee FR; Pallanti S
    Am J Psychiatry; 1997 Mar; 154(3):396-401. PubMed ID: 9054789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clomipramine in obsessive compulsive disorder.
    Lee S
    J Clin Psychiatry; 1991 Apr; 52(4):183-5. PubMed ID: 2016256
    [No Abstract]   [Full Text] [Related]  

  • 49. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder.
    Bisserbe J; Lane R; Flament M;
    Eur Psychiatry; 1997; 12(2):82-93. PubMed ID: 19698511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study.
    Mundo E; Bareggi SR; Pirola R; Bellodi L; Smeraldi E
    J Clin Psychopharmacol; 1997 Feb; 17(1):4-10. PubMed ID: 9004050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine.
    Berman I; Sapers BL; Chang HH; Losonczy MF; Schmildler J; Green AI
    J Clin Psychopharmacol; 1995 Jun; 15(3):206-10. PubMed ID: 7635998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical experience in the treatment of obsessional states (2).
    Rack PH
    J Int Med Res; 1977; 5 Suppl 5():81-90. PubMed ID: 598609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.
    Koran LM; McElroy SL; Davidson JR; Rasmussen SA; Hollander E; Jenike MA
    J Clin Psychopharmacol; 1996 Apr; 16(2):121-9. PubMed ID: 8690827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
    Albert U; Aguglia E; Maina G; Bogetto F
    J Clin Psychiatry; 2002 Nov; 63(11):1004-9. PubMed ID: 12444814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clomipramine (Anafranil) in depressive patients with obsessive neurosis.
    Singh AN; Sexena B; Gent M
    J Int Med Res; 1977; 5 Suppl 5():25-32. PubMed ID: 598603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Symptom Checklist-90: Obsessive-Compulsive Subscale: A reliability and validity study.
    Kim SW; Dysken MW; Kuskowski M
    Psychiatry Res; 1992 Jan; 41(1):37-44. PubMed ID: 1561287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA; L'Heureux F; Hill JL; Bihari K; Bernstein SE; Murphy DL
    J Clin Psychopharmacol; 1992 Feb; 12(1):11-8. PubMed ID: 1552034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.
    Noorbala AA; Hosseini SH; Mohammadi MR; Akhondzadeh S
    J Clin Pharm Ther; 1998 Apr; 23(2):155-9. PubMed ID: 9786103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling).
    Swedo SE; Leonard HL; Rapoport JL; Lenane MC; Goldberger EL; Cheslow DL
    N Engl J Med; 1989 Aug; 321(8):497-501. PubMed ID: 2761586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.